ADOC and ADOCY Related Headlines

Go Back

Jun 11, 2026 12:00PM Number of Shares and Voting Rights of ADOCIA as of May 31st, 2026
Jun 10, 2026 12:00PM ADOCIA Confirms its Eligibility for the PEA‑PME Scheme
Jun 8, 2026 01:01AM ADOCIA presents phase 3 data for diabetes insulin at ADA conference
Jun 8, 2026 01:00AM ADOCIA Announces THDB0206 (BioChaperone® Lispro) Phase 3 Data in Type 2 Diabetes Presented at ADA 86th Scientific Sessions, Confirming the Positive Results Previously Announced in July 2025
Jun 4, 2026 12:00PM Adocia to host virtual event on Phase 3 insulin trial results
Jun 4, 2026 12:00PM Adocia Announces a Virtual KOL Event to Review the Phase 3 Results of the Ultra-Rapid Insulin BioChaperone® Lispro on June 16, 2026
May 12, 2026 12:00PM ADOCIA Reports First Quarter 2026 Financial Results and Provides a Business Update
May 11, 2026 12:00PM ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 3rd, 2026 in Paris
May 7, 2026 12:00PM Number of Shares and Voting Rights of ADOCIA as of April 30, 2026
Apr 29, 2026 12:00PM ADOCIA Announces the Release of its Universal Registration Document for the Year 2025
Apr 21, 2026 02:30PM ADOCIA Announces Full Year 2025 Financial Results and Provides a Corporate and Financial Update
Apr 21, 2026 01:30PM ADOCIA and Vester Finance sign a shareholder loan agreement, enabling ADOCIA to extend its cash runway until beginning Q2 2027
Apr 10, 2026 12:00PM Number of Shares and Voting Rights of ADOCIA as of March 31st, 2026
Mar 6, 2026 12:00PM Number of Shares and Voting Rights of ADOCIA as of February 28th, 2026
Feb 24, 2026 12:00PM ADOCIA Reports Fourth Quarter 2025 Financial Results and Provides a Business Update
Feb 6, 2026 12:00PM Number of Shares and Voting Rights of ADOCIA as of January 31st, 2026
Jan 22, 2026 12:00PM ADOCIA Announces Half-Year Report on Adocia’s Liquidity Agreement with Kepler Capital Markets
Jan 9, 2026 12:00PM Number of Shares and Voting Rights of ADOCIA as of December 31st, 2025
Dec 18, 2025 12:00PM ADOCIA Announces its Financial Calendar for 2026
Dec 8, 2025 01:30PM Number of Shares and Voting Rights of ADOCIA as of December 8th, 2025
Nov 14, 2025 12:00PM Number of Shares and Voting Rights of ADOCIA as of October 31st, 2025
Nov 12, 2025 01:30AM ADOCIA Announces Filing of Patent for New Long-Acting Peptides Platform in Diabetes and Obesity - AdoXLong™ - and Provides an Update on its BioChaperone® Platform
Oct 15, 2025 12:00PM ADOCIA Reports Third Quarter 2025 Financial Results and Provides a Business Update
Oct 15, 2025 02:45AM ADOCIA reports positive phase 3 trial results for diabetes insulin
Oct 15, 2025 02:45AM ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in people with T1D
Oct 10, 2025 12:00PM Number of Shares and Voting Rights of ADOCIA as of September 30th, 2025
Sep 25, 2025 12:00PM ADOCIA Announces First Half 2025 Financial Results and Provides a Business Update
Sep 11, 2025 12:00PM Number of Shares and Voting Rights of ADOCIA as of August 31st, 2025
Sep 3, 2025 12:00PM ADOCIA Announces Oral Presentations on AdoShell® and BioChaperone® at EASD, ESB and PODD 2025 Annual Meetings
Aug 19, 2025 12:00PM Number of Shares and Voting Rights of ADOCIA as of July 31st, 2025
Jul 25, 2025 02:45AM ADOCIA and Tonghua Dongbao report positive phase 3 insulin trial results
Jul 25, 2025 02:45AM ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in People with T2D
Jul 23, 2025 12:00PM ADOCIA Reports Second Quarter 2025 Financial Results and Provides a Business Update
Jul 16, 2025 12:00PM ADOCIA Announces Half-Year Report on Adocia’s Liquidity Agreement with Kepler Capital Markets
Jul 11, 2025 12:00PM Number of Shares and Voting Rights of ADOCIA as of June 30th, 2025

ADOC and ADOCY Related Press Releases

Go Back

Jun 11, 2026 12:00PM Number of Shares and Voting Rights of ADOCIA as of May 31st, 2026
Jun 10, 2026 12:00PM ADOCIA Confirms its Eligibility for the PEA‑PME Scheme
Jun 8, 2026 01:00AM ADOCIA Announces THDB0206 (BioChaperone® Lispro) Phase 3 Data in Type 2 Diabetes Presented at ADA 86th Scientific Sessions, Confirming the Positive Results Previously Announced in July 2025
Jun 4, 2026 12:00PM Adocia Announces a Virtual KOL Event to Review the Phase 3 Results of the Ultra-Rapid Insulin BioChaperone® Lispro on June 16, 2026
May 12, 2026 12:00PM ADOCIA Reports First Quarter 2026 Financial Results and Provides a Business Update
May 11, 2026 12:00PM ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 3rd, 2026 in Paris
May 7, 2026 12:00PM Number of Shares and Voting Rights of ADOCIA as of April 30, 2026
Apr 29, 2026 12:00PM ADOCIA Announces the Release of its Universal Registration Document for the Year 2025
Apr 21, 2026 02:30PM ADOCIA Announces Full Year 2025 Financial Results and Provides a Corporate and Financial Update
Apr 21, 2026 01:30PM ADOCIA and Vester Finance sign a shareholder loan agreement, enabling ADOCIA to extend its cash runway until beginning Q2 2027
Apr 10, 2026 12:00PM Number of Shares and Voting Rights of ADOCIA as of March 31st, 2026
Mar 6, 2026 12:00PM Number of Shares and Voting Rights of ADOCIA as of February 28th, 2026
Feb 24, 2026 12:00PM ADOCIA Reports Fourth Quarter 2025 Financial Results and Provides a Business Update
Feb 6, 2026 12:00PM Number of Shares and Voting Rights of ADOCIA as of January 31st, 2026
Jan 22, 2026 12:00PM ADOCIA Announces Half-Year Report on Adocia’s Liquidity Agreement with Kepler Capital Markets
Jan 9, 2026 12:00PM Number of Shares and Voting Rights of ADOCIA as of December 31st, 2025
Dec 18, 2025 12:00PM ADOCIA Announces its Financial Calendar for 2026
Dec 8, 2025 01:30PM Number of Shares and Voting Rights of ADOCIA as of December 8th, 2025
Nov 14, 2025 12:00PM Number of Shares and Voting Rights of ADOCIA as of October 31st, 2025
Nov 12, 2025 01:30AM ADOCIA Announces Filing of Patent for New Long-Acting Peptides Platform in Diabetes and Obesity - AdoXLong™ - and Provides an Update on its BioChaperone® Platform
Oct 15, 2025 12:00PM ADOCIA Reports Third Quarter 2025 Financial Results and Provides a Business Update
Oct 15, 2025 02:45AM ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in people with T1D
Oct 10, 2025 12:00PM Number of Shares and Voting Rights of ADOCIA as of September 30th, 2025
Sep 25, 2025 12:00PM ADOCIA Announces First Half 2025 Financial Results and Provides a Business Update
Sep 11, 2025 12:00PM Number of Shares and Voting Rights of ADOCIA as of August 31st, 2025
Sep 3, 2025 12:00PM ADOCIA Announces Oral Presentations on AdoShell® and BioChaperone® at EASD, ESB and PODD 2025 Annual Meetings
Aug 19, 2025 12:00PM Number of Shares and Voting Rights of ADOCIA as of July 31st, 2025
Jul 25, 2025 02:45AM ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in People with T2D
Jul 23, 2025 12:00PM ADOCIA Reports Second Quarter 2025 Financial Results and Provides a Business Update
Jul 16, 2025 12:00PM ADOCIA Announces Half-Year Report on Adocia’s Liquidity Agreement with Kepler Capital Markets
Jul 11, 2025 12:00PM Number of Shares and Voting Rights of ADOCIA as of June 30th, 2025

ADOC and ADOCY Related SEC Filings

Go Back